ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$58.16
arrow_upward
+1.22%(+0.70) 1D
$58.16
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$58.21
High
$58.71
Low
$57.00
Mkt. cap
8.22B
Avg. vol.
1.73M
Volume
1.36M
52-wk high
$95.49
52-wk low
$37.06
EPS
-$2.24
Beta
1.34
Shares outstanding
141.25M
No. of employees
711
Open
$58.21
High
$58.71
Low
$57.00
Mkt. cap
8.22B
Avg. vol.
1.73M
Volume
1.36M
52-wk high
$95.49
52-wk low
$37.06
EPS
-$2.24
Beta
1.34
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Investing.com
·
1 day ago
Arrowhead Pharmaceuticals options signal 8.1% move on earnings
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorHealth Care
IndustryBiotechnology
Websitearrowheadpharma.com